Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $61.08MP/E –Yield –
Nuo Therapeutics cash
Cash and short-term investments held at the end of each period.
Nuo Therapeutics's cash was $80.94K at Sep 30, 2026. For fiscal 2025 it was $548.95K, up 93.5% from the year before. Over ten years it grew -5.1% a year on average. The highest annual figure on record is $15.95M in fiscal 2014.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $548.95K | +93.5% |
| FY2024 | Dec 31, 2024 | $283.71K | -69.4% |
| FY2023 | Dec 31, 2023 | $928.68K | -54.7% |
| FY2022 | Dec 31, 2022 | $2.05M | +45.0% |
| FY2021 | Dec 31, 2021 | $1.41M | +776.3% |
| FY2020 | Dec 31, 2020 | $161.43K | +697.1% |
| FY2019 | Dec 31, 2019 | $20.25K | -96.8% |
| FY2018 | Dec 31, 2018 | $636.93K | -8.2% |
| FY2017 | Dec 31, 2017 | $693.52K | -73.5% |
| FY2016 | Dec 31, 2016 | $2.62M | +184.1% |
| FY2015 | Dec 31, 2015 | $922.32K | -94.2% |
| FY2014 | Dec 31, 2014 | $15.95M | +385.2% |
| FY2013 | Dec 31, 2013 | $3.29M | +25.6% |
| FY2012 | Dec 31, 2012 | $2.62M | +16.5% |
| FY2011 | Dec 31, 2011 | $2.25M | +251.6% |
| FY2010 | Dec 31, 2010 | $638.87K | -69.7% |
| FY2009 | Dec 31, 2009 | $2.11M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $80.94K | -84.3% |
| Q2 FY2026 | Jun 30, 2026 | $449.33K | +42.0% |
| Q1 FY2026 | Mar 31, 2026 | $263.83K | +374.0% |
| Q4 FY2025 | Dec 31, 2025 | $548.95K | +93.5% |
| Q3 FY2025 | Sep 30, 2025 | $514.80K | -24.7% |
| Q2 FY2025 | Jun 30, 2025 | $316.35K | -33.1% |
| Q1 FY2025 | Mar 31, 2025 | $55.66K | -84.8% |
| Q4 FY2024 | Dec 31, 2024 | $283.71K | -69.4% |
| Q3 FY2024 | Sep 30, 2024 | $683.84K | +17.4% |
| Q2 FY2024 | Jun 30, 2024 | $473.04K | +37.4% |
| Q1 FY2024 | Mar 31, 2024 | $366.23K | -70.7% |
| Q4 FY2023 | Dec 31, 2023 | $928.68K | -54.7% |
| Q3 FY2023 | Sep 30, 2023 | $582.59K | -79.8% |
| Q2 FY2023 | Jun 30, 2023 | $344.37K | -90.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.25M | +87.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.05M | +45.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.88M | +1838.7% |
| Q2 FY2022 | Jun 30, 2022 | $3.44M | +2172.5% |
| Q1 FY2022 | Mar 31, 2022 | $665.39K | +323.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.41M | +776.3% |
| Q3 FY2021 | Sep 30, 2021 | $148.43K | – |
| Q2 FY2021 | Jun 30, 2021 | $151.59K | +1165938.5% |
| Q1 FY2021 | Mar 31, 2021 | $157.26K | +1303.0% |
| Q4 FY2020 | Dec 31, 2020 | $161.43K | +697.1% |
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $13 | -99.9% |
| Q1 FY2020 | Mar 31, 2020 | $11.21K | -94.0% |
| Q4 FY2019 | Dec 31, 2019 | $20.25K | -96.8% |
| Q3 FY2019 | Sep 30, 2019 | $17.33K | -93.1% |
| Q2 FY2019 | Jun 30, 2019 | $9.04K | -97.6% |
| Q1 FY2019 | Mar 31, 2019 | $185.31K | +26.1% |
| Q4 FY2018 | Dec 31, 2018 | $636.93K | -8.2% |
| Q3 FY2018 | Sep 30, 2018 | $250.17K | -87.0% |
| Q2 FY2018 | Jun 30, 2018 | $373.29K | +12.8% |
| Q1 FY2018 | Mar 31, 2018 | $146.94K | -89.0% |
| Q4 FY2017 | Dec 31, 2017 | $693.52K | -73.5% |
| Q3 FY2017 | Sep 30, 2017 | $1.92M | – |
| Q2 FY2017 | Jun 30, 2017 | $331.03K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.62M | – |
See a number that looks wrong?